LS Investment Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

LS Investment Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,108	Closed	-$25K	–	828
2020 Q2	$25K	Hold	1,108	–	–	﹤0.01%	1337
2020 Q1	$16K	Hold	1,108	–	–	﹤0.01%	1427
2019 Q4	$21K	Sell	1,108 -2,571	-70%	-$49.3K	﹤0.01%	1527
2019 Q3	$73K	Hold	3,679	–	–	﹤0.01%	1172
2019 Q2	$78K	Hold	3,679	–	–	﹤0.01%	1167
2019 Q1	$75K	Buy	3,679 +157	+4%	+$3.52K	﹤0.01%	1167
2018 Q4	$70K	Buy	3,522 +2,414	+218%	+$47.6K	﹤0.01%	1171
2018 Q3	$21K	Hold	1,108	–	–	﹤0.01%	1563
2018 Q2	$17K	Hold	1,108	–	–	﹤0.01%	1617
2018 Q1	$21K	Hold	1,108	–	–	﹤0.01%	1547
2017 Q4	$21K	Sell	1,108 -377	-25%	-$7.04K	﹤0.01%	1547
2017 Q3	$27K	Hold	1,485	–	–	﹤0.01%	1525
2017 Q2	$27K	Hold	1,485	–	–	﹤0.01%	1514
2017 Q1	$22K	Hold	1,485	–	–	﹤0.01%	1545
2016 Q4	$27K	Hold	1,485	–	–	﹤0.01%	1472
2016 Q3	$28K	Buy	+1,485	New	+$27K	﹤0.01%	1421

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LS Investment Advisors's AMPH Position: Q3 2020 in Review

LS Investment Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2020, closing a stake of 1,108 shares — an estimated $25K sold.

LS Investment Advisors first reported a position in AMPH in Q3 2016 and held it in 16 quarters. The position peaked at $78K in Q2 2019. 136 funds tracked by Wall St. Rank hold AMPH as of Q3 2020.

LS Investment Advisors reported no remaining Amphastar Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
LS Investment Advisors sold 1,108 Amphastar Pharmaceuticals shares in Q3 2020, an estimated $25K.
LS Investment Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 16 quarters.
LS Investment Advisors's Amphastar Pharmaceuticals position peaked at $78K in Q2 2019.
136 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.